We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ATNF market cap is 2.71M. The company's latest EPS is USD -10.0835 and P/E is -0.13.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.6M | -1.45M | -2.09M | -1.85M | -979k |
| Net Income | -10.27M | -1.23M | -1.07M | 12k | -837k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.21M | -5.65M | -15.64M | -51.45M | -22.54M |
| Net Income | -91k | -10.88M | -20.32M | -38.73M | -19.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.96M | 5.26M | 3.44M | 3.91M | 10.47M |
| Total Liabilities | 5.11M | 5.39M | 4.4M | 4.33M | 6.74M |
| Total Equity | -149k | -128k | -954k | -418k | 3.73M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 12.5M | 55.53M | 62.71M | 19.65M | 5.26M |
| Total Liabilities | 7.16M | 25.25M | 23.39M | 8.31M | 5.39M |
| Total Equity | 5M | 30.29M | 39.32M | 11.34M | -128k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.76M | -10.92M | -1.03M | -306k | -530k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 4.44M | 5.91M | -265k | -530k | -1.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.45M | -3.87M | -19.37M | -12.13M | -10.92M |
| Investing | 108.24M | 14.49M | N/A | N/A | N/A |
| Financing | -106.51M | -8.73M | 25.41M | 10.87M | 5.91M |
| Market Cap | 2.71M |
| Price to Earnings Ratio | -0.13 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.35 |
| Price to Book Ratio | -20.85 |
| Dividend Yield | - |
| Shares Outstanding | 1.98M |
| Average Volume (1 week) | 118.65k |
| Average Volume (1 Month) | 212.97k |
| 52 Week Change | -63.95% |
| 52 Week High | 17.75 |
| 52 Week Low | 1.18 |
| Spread (Intraday) | 0.04 (2.92%) |
| Company Name | 180 Life Sciences Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.180lifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
